After just uplisting to the TSX in Canada, Field Trip Health has applied to uplist to the NASDAQ in the U.S.

Seattle lawmakers on Monday sent a letter to members of a local task force focused on the opioid overdose epidemic, imploring the group to investigate the therapeutic potential of psychedelics like ayahuasca and ibogaine in curbing addiction.

HaluGen Life Sciences’ test evaluates an individual’s overall sensitivity and risk profile associated with psychedelic-assisted therapy

In 2014, during my first pregnancy, I felt happy and healthy almost all the time.

Just in time for summer, Heritage Cannabis Holdings Corp. has announced the launch of RADsicles, a cannabis-infused frozen edible meant to help consumers beat the heat with an intoxicating twist.

Optimi Health’s new distribution agreement with Vitasave provides retail access to two of Canada’s largest urban markets.

Red Light Holland’s new tech acquisition is intended to help optimize psychedelics dosing.

Cybin is launching a new clinical trial to address “COVID-related burnout and distress”, supported by its new EMBARK psychotherapy model.

Mydecine announces identifying 40 previously unknown “novel compounds” among dozens of mushroom species it has screened.